About Us
Home About Us
Company Overview

Veritas Therapeutics Inc. is the newly founded commercialization arm associated with the Toronto Transplant Institute (TTI) located at the

 University Health Network/University of Toronto in Toronto, Ontario, Canada. TTI and its predecessor, the Multi Organ Transplant (MOT) program are the largest transplant program in Canada and one of the largest in the world.
 
 
 
The affiliated hospitals associated with the TTI (Toronto General Hospital, Hospital for Sick Children and St. Michael's Hospital) perform over 650 solid organ transplants per year and provide long term care for over 5000 transplant recipients, 
and have one of the most active education and training and research programs in the world.
 
 
 
Veritas has been established to bridge the gap from basic research findings to commercial products. The company is located in and has evolved from our successful Industrial BioDevelopment Laboratory (IBDL) that was created 6 years ago in the Toronto Medical Discovery Tower in the heart of Canada's Biotechnology centre. The infrastructure available includes a state of the art bioprocessing and bioanalytical laboratory capable of producing proof of principle biodiagnostic and biotherapeutic products.